BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34233329)

  • 1. Betahistine in Ménière's Disease or Syndrome: A Systematic Review.
    Van Esch B; van der Zaag-Loonen H; Bruintjes T; van Benthem PP
    Audiol Neurootol; 2022; 27(1):1-33. PubMed ID: 34233329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic pharmacological interventions for Ménière's disease.
    Webster KE; Galbraith K; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015171. PubMed ID: 36827524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive pressure therapy for Ménière's disease or syndrome.
    van Sonsbeek S; Pullens B; van Benthem PP
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD008419. PubMed ID: 25756795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic corticosteroids for Ménière's disease.
    Webster KE; Lee A; Galbraith K; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Westerberg B; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015245. PubMed ID: 36847608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratympanic gentamicin for Ménière's disease.
    Webster KE; Galbraith K; Lee A; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015246. PubMed ID: 36847592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifestyle and dietary interventions for Ménière's disease.
    Webster KE; George B; Lee A; Galbraith K; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Murdin L; Ray J; Van Vugt VA; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015244. PubMed ID: 36848645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical interventions for Ménière's disease.
    Lee A; Webster KE; George B; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015249. PubMed ID: 36825750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive pressure therapy for Ménière's disease.
    Webster KE; George B; Galbraith K; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015248. PubMed ID: 36815713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic and surgical therapies for patients with Meniere's disease: A systematic review and network meta-analysis.
    Ahmadzai N; Cheng W; Kilty S; Esmaeilisaraji L; Wolfe D; Bonaparte J; Schramm D; Fitzpatrick E; Lin V; Skidmore B; Hutton B
    PLoS One; 2020; 15(9):e0237523. PubMed ID: 32870918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Betahistine for Menière's disease or syndrome.
    James AL; Burton MJ
    Cochrane Database Syst Rev; 2001; 2001(1):CD001873. PubMed ID: 11279734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome.
    Hussain K; Murdin L; Schilder AG
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012173. PubMed ID: 30596397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratympanic gentamicin for Ménière's disease or syndrome.
    Pullens B; van Benthem PP
    Cochrane Database Syst Rev; 2011 Mar; (3):CD008234. PubMed ID: 21412917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Betahistine for tinnitus.
    Wegner I; Hall DA; Smit AL; McFerran D; Stegeman I
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013093. PubMed ID: 30908589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report from a Consensus Conference on the treatment of Ménière's disease with betahistine: rationale, methodology and results.
    Casani AP; Guidetti G; Schoenhuber R;
    Acta Otorhinolaryngol Ital; 2018 Oct; 38(5):460-467. PubMed ID: 30498275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Betahistine hydrochloride in Méniére's disease.
    Frew IJ; Menon GN
    Postgrad Med J; 1976 Aug; 52(610):501-3. PubMed ID: 790351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using betahistine in the treatment of patients with Menière's disease: a meta-analysis with the current randomized-controlled evidence.
    Devantier L; Hougaard D; Händel MN; Liviu-Adelin Guldfred F; Schmidt JH; Djurhuus B; Callesen HE
    Acta Otolaryngol; 2020 Oct; 140(10):845-853. PubMed ID: 32580600
    [No Abstract]   [Full Text] [Related]  

  • 17. Betahistine for symptoms of vertigo.
    Murdin L; Hussain K; Schilder AG
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD010696. PubMed ID: 27327415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial).
    Adrion C; Fischer CS; Wagner J; Gürkov R; Mansmann U; Strupp M;
    BMJ; 2016 Jan; 352():h6816. PubMed ID: 26797774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of clinical studies with betahistine in Ménière's disease and vestibular vertigo.
    Nauta JJ
    Eur Arch Otorhinolaryngol; 2014 May; 271(5):887-97. PubMed ID: 23778722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menière's disease.
    James AL; Thorp MA
    BMJ Clin Evid; 2007 Mar; 2007():. PubMed ID: 19454061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.